Merck (MRK) Provides Update on Phase 3 KEYNOTE-585 Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/6/2026

1. HUBS
2. WDC
3. SNDK
4. KVYO
5. APP
6. DASH
7. ZG
8. XYZ
9. DOX
10. PAYC

Go back to Merck (MRK) Provides Update on Phase 3 KEYNOTE-585 Trial
Merck & Co. (NYSE: MRK) Delayed: 128.37 +0.04 (0.03%)
Previous Close $128.33    52 Week High $65.46 
Open $130.96    52 Week Low $47.97 
Day High $131.08    P/E 87.33 
Day Low $127.80    EPS $1.47 
Volume 7,052,011